Disclosure about Fair Value of Financial Instruments (Details 1) $ in Thousands	Dec. 31, 2016 USD ($)
The Market approach utilized to measure fair value of financial assets and liabilities on recurring basis
Available-for-sale equity investments	$ 27,899	[1]
Foreign currency forward contract	131,219	[2]
Redeemable OP Unit holder Interests	110,502
Total	269,620
Level 1 [Member]
The Market approach utilized to measure fair value of financial assets and liabilities on recurring basis
Available-for-sale equity investments	27,899	[1]
Foreign currency forward contract	0	[2]
Redeemable OP Unit holder Interests	0
Total	27,899
Level 2 [Member]
The Market approach utilized to measure fair value of financial assets and liabilities on recurring basis
Available-for-sale equity investments	0	[1]
Foreign currency forward contract	131,219	[2]
Redeemable OP Unit holder Interests	110,502
Total	241,721
Level 3 [Member]
The Market approach utilized to measure fair value of financial assets and liabilities on recurring basis
Available-for-sale equity investments	0	[1]
Foreign currency forward contract	0	[2]
Redeemable OP Unit holder Interests	0
Total	$ 0

[1] Unrealized gains or losses on equity investments are recorded in accumulated other comprehensive income (loss) at each measurement date. During the year ended December 31, 2015, we recognized an other than temporary impairment charge of $35,648,000 on the Genesis Healthcare stock investment. Also, see Note 11 for details related to the gain on the derivative asset originally recognized.

[2] Please see Note 11 for additional information.